mitoxantrone has been researched along with Otitis Media, Purulent in 1 studies
Mitoxantrone: An anthracenedione-derived antineoplastic agent.
mitoxantrone : A dihydroxyanthraquinone that is 1,4-dihydroxy-9,10-anthraquinone which is substituted by 6-hydroxy-1,4-diazahexyl groups at positions 5 and 8.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Olalla, I | 1 |
| Ortín, M | 1 |
| Hermida, G | 1 |
| Cortés, MA | 1 |
| Richard, C | 1 |
| Iriondo, A | 1 |
| Mozota, ML | 1 |
| Zubizarreta, A | 1 |
1 other study available for mitoxantrone and Otitis Media, Purulent
| Article | Year |
|---|---|
Autologous peripheral blood stem cell transplantation in a patient with previous invasive middle ear mucormycosis.
Topics: Acute Disease; Amphotericin B; Antifungal Agents; Antineoplastic Combined Chemotherapy Protocols; Co | 1996 |